Progenics: Jefferies Global Healthcare Conference (Progenics) - Jun 5, 2015 - “PSMA ADC: CTC Responses in Chemo-Naïve Patients, CTC reductions of greater than or equal to 50% in 89% of patients”; “Biomarkers Correlate CTC Response to PSMA ADC, Evaluable chemo-naïve patients (≥ 5 CTCs at baseline)”
P2 data • Oncology • Prostate Cancer
|